These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Detection of adriamycin cardiotoxicity by echocardiography. Ewy GA; Jones SE; Groves BM; Gaines JA Ariz Med; 1978 Jun; 35(6):402-5. PubMed ID: 687134 [No Abstract] [Full Text] [Related]
3. [The significance of notches or bites in the vectorcardiogram. Study in cardiopathy caused by adriamycin]. Vitolo E; Madoi S; Roveda M; Larovere MT; Beretta G; Obbiassi M Boll Soc Ital Cardiol; 1980; 25(9):1073-5. PubMed ID: 7284195 [No Abstract] [Full Text] [Related]
4. Myocardial imaging with Cc-99m pyrophosphate in patients on adriamycin treatment for neoplasia. Chacko AK; Gordon DH; Bennett JM; O'Mara RE; Wilson GA J Nucl Med; 1977 Jul; 18(7):680-3. PubMed ID: 194931 [TBL] [Abstract][Full Text] [Related]
6. Noninvasive cardiac evaluation of patients receiving adriamycin. Ewy GA; Jones SE; Friedman MJ; Gaines J; Cruze D Cancer Treat Rep; 1978 Jun; 62(6):915-22. PubMed ID: 667868 [No Abstract] [Full Text] [Related]
7. Echocardiographic evaluation of adriamycin cardiotoxicity in children. Ramos A; Meyer RA; Korfhagen J; Wong KY; Kaplan S Cancer Treat Rep; 1976 Sep; 60(9):1281-4. PubMed ID: 1016964 [TBL] [Abstract][Full Text] [Related]
8. [Serial echocardiographic evaluation of the cardiotoxicity of adriamycin and therapeutic protocols]. Villecco AS; Cagnano R; De Liberali E; Ferrari G; Musacchio M; Di Paolo E Cardiologia; 1985 May; 30(5):395-9. PubMed ID: 3833352 [No Abstract] [Full Text] [Related]
9. Adriamycin in management of malignant hemangiopericytoma. Morris DM; Vuthiganon C; Chang P; Wiernik PH; Elias EG Am Surg; 1981 Oct; 47(10):441-6. PubMed ID: 7305129 [No Abstract] [Full Text] [Related]
10. [Polycardiographic evaluation of the cardiotoxicity of adriamycin]. Villani F; Beretta G; Guindani A; Pagnoni A; Vivarelli S G Ital Chemioter; 1975; 22(1-2):39-46. PubMed ID: 1235351 [No Abstract] [Full Text] [Related]
11. Effect of a 1-hour IV infusion of doxorubicin on the development of cardiotoxicity in dogs as evaluated by electrocardiography and echocardiography. Gillings S; Johnson J; Fulmer A; Hauck M Vet Ther; 2009; 10(1-2):46-58. PubMed ID: 19742448 [TBL] [Abstract][Full Text] [Related]
12. [Non-invasive methods in the monitoring of patients treated with adriamycin]. Rozo L; Carlier R; Fumoleau P; Nicolas G Arch Mal Coeur Vaiss; 1981 Nov; 74(11):1341-8. PubMed ID: 6797373 [No Abstract] [Full Text] [Related]
13. Cardiotoxicity in children treated with anthracyclines: the role of M-mode echocardiography. Galli MA; Conter V; Zanetto F; Jankovic M; Ferrari L; Baio G; Masera G Haematologica; 1987; 72(4):347-50. PubMed ID: 3117636 [No Abstract] [Full Text] [Related]
15. Comparative analysis of noninvasive cardiac parameters in the detection and evaluation of adriamycin cardiotoxicity. Shuman RD; Ettinger DS; Abeloff MD; Livengood SV; Fortuin NJ Johns Hopkins Med J; 1981 Aug; 149(2):57-63. PubMed ID: 7253365 [TBL] [Abstract][Full Text] [Related]
16. [Control of cardiac function during therapy with doxorubicin and other anthracyclines]. Grille W; Johnsen K; Kolenda KD; Schöttler M; Löffler H Dtsch Med Wochenschr; 1985 Jul; 110(28-29):1134-7. PubMed ID: 3859399 [No Abstract] [Full Text] [Related]
17. A comparison of cardiac biopsy grades and ejection fraction estimations in patients receiving Adriamycin. Ewer MS; Ali MK; Mackay B; Wallace S; Valdivieso M; Legha SS; Benjamin RS; Haynie TP J Clin Oncol; 1984 Feb; 2(2):112-7. PubMed ID: 6699662 [TBL] [Abstract][Full Text] [Related]